Nano Biotechnology & Nanomedicine
PhD: Structural Biology, Weizmann Institute of Sciences, 2002
MSc: Biochemistry, Tel-Aviv University, 1998
BSc: Biology, Tel-Aviv University, 1996
Post Doc: Northwestern University, 2019
MD.: Technion. 2011
B.Sc.: BmedSc, Ben Gurion University, 2006
Main Nano Field: Cell biology, molecular biology
Research interests: Genetic Skin Diseases
Post Doc: Northwestern University, 2019
MD.: Technion. 2011
B.Sc.: BmedSc, Ben Gurion University, 2006
Main Nano Field: Cell biology, molecular biology
Research interests: Genetic Skin Diseases
Ph.D.: Biochemistry and cell biology, Hebrew University of Jerusalem, 2014
M.Sc.: Genetics, Ben Gurion University, 2006
B.Sc.: Biotechnoligcal engineering, Ben Gurion University, 2004
Industry experience: Manager of the DNA markers development unit, Hazera Genetics inc., 2006-2009
Ph.D.: Human genetics, The Hebrew University, 2012
M.Sc.: Genetics, The Hebrew University, 2005
B.Sc.: Biology, The Hebrew University, 2003
Main Nano Field: Drug development and delivery
Research interests: Cancer genetics, non-coding RNA, Gene editing, gene regulation, Drug resistance
Ph.D.: Biochemistry, Federal University of Rio de Janeiro, Brazil, 1996;
M.D.: Medicine, Federal University of Rio de Janeiro, Brazil, 1994
Main Nano Field: Nanotechnology in Neuroscience
Ph.D.: Medicinal Chemistry, The Institute for Drug Research-School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, 2014
M.Sc.: (Direct track to PhD) Medicinal Chemistry, The Institute for Drug Research-School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, 2014
B.Sc.: Medicinal Chemistry, The Institute for Drug Research-School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, 2014
Ph.D.: Ben Gurion University of the Negev, 2013
M.Sc.: Chemistry and Clinical Pharmacology, Ben Gurion University of the Negev, 2008
B.Sc.: Chemistry, Ben Gurion University of the Negev, 2005
Main Nano Field: Targeting the tumor vasculature multi-functional nanomedicines, Nanoinformatics using quantitative structure-nanoparticle assembly prediction (QSNAP), drug-dye nanocrystals
